ADC Therapeutics ADCT
NYSE ADCT
$1.50 -0.02 (-1.64%)
As of: Oct 21, 2026 · 3:59 PM EDT

ADC Therapeutics (ADCT) EBT (2020 - 2026)

Updated

ADC Therapeutics (ADCT) recorded EBT of -$16.57 million in Q2 2026, compared with -$55.39 million a year earlier.

Analysis

ADC Therapeutics (ADCT) EBT (2020 - 2026) Analysis & Trends

On a TTM basis, ADC Therapeutics' EBT came in at -$145.89 million as of Jun 30, 2026.

  • The Q2 2026 figure is the highest quarterly EBT in data going back to Q1 2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 9.25 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 6.75 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 4.28 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -683.00 Mn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 4.27 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 2.80 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 2.77 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -10.25 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -653.00 Mn
10 ADC Therapeutics 231.75 Mn -714.44 Mn 16.90 Mn -16.57 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -16.57 Mn
Mar 31, 2026 -32.97 Mn
Sep 30, 2025 -40.97 Mn
Jun 30, 2025 -55.39 Mn
Mar 31, 2025 -38.44 Mn
Sep 30, 2024 -43.62 Mn
Jun 30, 2024 -35.71 Mn
Mar 31, 2024 -45.80 Mn
Sep 30, 2023 -45.40 Mn
Jun 30, 2023 -52.70 Mn
Mar 31, 2023 -59.69 Mn
Sep 30, 2022 -51.32 Mn
Jun 30, 2022 -65.32 Mn
Mar 31, 2022 -17.83 Mn
Sep 30, 2021 -71.40 Mn
Jun 30, 2021 -72.33 Mn
Mar 31, 2021 -51.42 Mn
Sep 30, 2020 -20.33 Mn
Jun 30, 2020 -126.45 Mn
Mar 31, 2020 -43.38 Mn
API Access

ADC Therapeutics EBT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebt&ticker=ADCT&period=max&api_key=YOUR_API_KEY